5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are 0.8% lower at 8,771.1 points on Thursday.

The world is waiting for a second round of talks between the US and Iran to commence in Islamabad.

Meanwhile, the Strait of Hormuz, a critical waterway through which 20% of the world's oil and gas supply is transported, remains effectively shut down.

The US blockade of Iranian ports also remains in place.

The US hopes that by blocking Iran's own oil exports, it can coerce a peace deal through economic hardship.

In a Truth Social post, US President Donald Trump said:

Iran is collapsing financially! They want the Strait of Hormuz opened immediately- Starving for cash! Losing 500 Million Dollars a day.

Military and Police complaining that they are not getting paid. SOS!!!

Amid the ongoing oil shock and fears of a global recession, brokers have indicated continuing confidence in several ASX 200 shares.

These companies received renewed buy ratings this week.

Let's review.

A team of people giving the thumbs up sign.

Image source: Getty Images

Cochlear Ltd (ASX: COH)

The Cochlear share price is $96.22, down 3.3%, after hitting a 52-week low of $95.81 earlier in the day.

Cochlear shares were smashed this week after the hearing implant device maker downgraded its earnings guidance.

UBS analyst David Low is looking past the downgrade, though, and reiterated his buy rating today.

Low has a 12-month target of $302 on this ASX 200 healthcare share.

This implies a potential 212% upside over the next 12 months.

Droneshield Ltd (ASX: DRO)

The Droneshield share price is $3.75, down 2.2% today.

This ASX 200 industrial share has fallen by 20% over six months.

However, it remains 210% higher over 12 months.

Bell Potter renewed its buy rating on Droneshield shares with a 12-month target of $4.80 today.

This implies a potential 27% capital gain ahead.

REA Group Ltd (ASX: REA)

The REA share price is $174.39, down 0.9% today.

This ASX 200 communications share has fallen 27% over 12 months, but is up 10% over the past four weeks.

Citi renewed its buy rating on REA shares today with a 12-month price target of $199.

This implies a potential 14% upside ahead.

South32 Ltd (ASX: S32)

The South32 share price is $4.39, down 2.4% today.

Year-to-date (YTD), this ASX 200 mining share has ripped 24% higher.

Citi renewed its buy rating on South32 shares today.

The broker has a target price of $5.40, implying a potential 23% upside over the next year.

Northern Star Resources Ltd (ASX: NST)

The Northern Star Resources share price is $22.48, down 1.4% today.

The ASX 200 gold share has lost 8% of its value over the YTD.

However, it has recently embarked on a major comeback, rising 31% over four weeks.

Citi reiterated its buy rating on Northern Star Resources shares this week.

The broker's price target is $29.70, suggesting another 30% growth ahead.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear and DroneShield. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three guys in shirts and ties give the thumbs down.
Broker Notes

5 ASX All Ords shares downgraded by brokers this week

Brokers have reduced their ratings on PLS Group, Fortescue, Webjet, and others this week.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Broker Notes

Does Ord Minnett rate Goodman shares as a buy, hold, or sell?

The broker has been looking at a big agreement signed this month.

Read more »

Red sell button on an Apple keyboard.
Broker Notes

Sell alert! Why this expert is calling time on Westpac shares

A leading analyst delivers his verdict on Westpac shares.

Read more »

A woman wearing a black and white striped t-shirt looks to the sky with her hand to her chin, contemplating buying ASX shares.
Broker Notes

Buy, hold, sell: Minerals 260, 4DMedical, Karoon Energy shares

Two experts share their latest ratings and opinions on three ASX shares.

Read more »

Two mining workers in orange high vis vests walk and talk at a mining site.
Resources Shares

Morgans tips 1 ASX mining share to rip — and 1 to avoid — in 2026

Morgans has revised its ratings on an ASX 200 lithium share and an ASX 200 gold stock.

Read more »

Woman and man calculating a dividend yield.
Broker Notes

What is Morgans saying about Stanmore Resources and Suncorp shares after results?

Are these shares a buy, hold, or sell?

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Up 170% in a year: Are Codan shares a buy?

Investors have more than doubled their money in 12 months with this stock.

Read more »

A person leans over to whisper a secret to a colleague during a meeting.
Broker Notes

Bell Potter is tipping this ASX All Ords share as a buy with 15% upside

Let's see which share the broker is recommending to clients.

Read more »